News search

Latest news

Melanoma study: are two immunotherapies better than one?
December 07, 2018

A newly opened Phase 3 study at Providence Cancer Institute hopes to shed new light on the benefits of two immunotherapies, nivolumab and NKTR-214, for patients with advanced melanoma.

Introducing Providence St. Joseph Health Digital Commons
December 06, 2018

Providence St. Joseph Health (PSJH) recently launched a new platform to highlight the scholarly activities of its providers, researchers and caregivers: Digital Commons. The institutional repository serves as a singular site to easily access and navigate PSJH journal articles, abstracts, book chapters, presentations and other materials.

New immunotherapy options for liver cancer
November 29, 2018

Checkpoint inhibitors are showing promise as a potential new line of treatment for people with liver cancer. The Earle A. Chiles Research Institute at Providence Cancer Institute currently has six studies open to liver cancer patients, including two new studies investigating checkpoint inhibitors.